SP today, page-81

Abdm

That's fine not 100% though, that's what I was correcting.


and from the broker report link from InToWin....

""Around half of the patients notionally gained some benefit. The 19%
response rate was for those patients where CA125 went down or only rose
slowly. Another five patients registered some response to the vaccine for
shorter periods, suggesting that around half of all patients gained some
benefit from the vaccine;""

..........................................

InToWin

I'm well aware that they were late stage patients,I have been following this coy for 2 years. I just provided you and the readers here with that information in the link. If I wanted to downramp it ( not just correct abdm's 100% claim/ramp) I wouldn't have added this to the same post..

""Cvac may achieve a simular outcome as Abagovomab in Cvac's phase 2b trial now that they are treating Patients in First or Second Remission but that will take time to evaluate because we are still recruiting for the trial.""

Nuf said from me, you are wasting my time.Bye